Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Asopa

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Clinical Nuclear Medicine|October 14, 2010
Interesting image. The search for primary tumor in a patient with oncogenic osteomalacia: F-18 FDG PET resolves the conundrumGaurav Malhotra, Archi Agrawal, Nirmala A Jambhekar, et al.
Nature Biotechnology|July 1, 1997
Immunoglobulin-like domains define the nerve growth factor binding site of the TrkA receptorP H Holden, V Asopa, A G Robertson, et al.
American Journal of Nuclear Medicine and Molecular Imaging|September 15, 2020
One decade of 'Bench-to-Bedside' peptide receptor radionuclide therapy with indigenous [<sup>177</sup>Lu]Lu-DOTATATE obtained through 'Direct' neutron activation route: lessons learnt including practice evolution in an Indian settingSandip Basu, Sudipta Chakraborty, Rahul V Parghane, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Clinical Nuclear Medicine|October 14, 2010
Interesting image. The search for primary tumor in a patient with oncogenic osteomalacia: F-18 FDG PET resolves the conundrumGaurav Malhotra, Archi Agrawal, Nirmala A Jambhekar, et al.
Nature Biotechnology|July 1, 1997
Immunoglobulin-like domains define the nerve growth factor binding site of the TrkA receptorP H Holden, V Asopa, A G Robertson, et al.
American Journal of Nuclear Medicine and Molecular Imaging|September 15, 2020
One decade of 'Bench-to-Bedside' peptide receptor radionuclide therapy with indigenous [<sup>177</sup>Lu]Lu-DOTATATE obtained through 'Direct' neutron activation route: lessons learnt including practice evolution in an Indian settingSandip Basu, Sudipta Chakraborty, Rahul V Parghane, et al.
Pageof 5